Vir Biotechnology, Inc.

📍 San Francisco, United States🗓 Founded 2016👥 576 employees💰 Last funded Jul 2020
Biotechnology Research🌐 vir.bio
Website LinkedIn
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world. We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™. Join us as we pursue our mission to transform lives. It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2018–2020 · investors recorded per year
2018220201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Vir Biotechnology, Inc.?
Vir Biotechnology, Inc. has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Vir Biotechnology, Inc. last raise funding?
The most recent investment in Vir Biotechnology, Inc. recorded on gritt.io was in July 2020.
When was Vir Biotechnology, Inc. founded?
Vir Biotechnology, Inc. was founded in 2016.
What industry is Vir Biotechnology, Inc. in?
Vir Biotechnology, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vir Biotechnology, Inc. based?
Vir Biotechnology, Inc. is headquartered in San Francisco, United States.